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Abstract
Background: Identifying the clinical phenotypes of  non-motor symptoms (NMSs) of  essential tremor (ET) among different populations is necessary due to their 
impact on the quality of  life (QoL). This study aimed to investigate the clinical phenotype and impact of  NMSs on QoL in Egyptian patients with ET.
Methods: Thirty ET patients were compared to 30 matched controls. Subjects were evaluated by the Fahn-Tolosa-Marin Tremor Rating Scale, Non-Motor 
Symptoms Scale (NMSS), Montreal Cognitive Assessment, Hamilton Anxiety Rating Scale, Beck Depression Inventory, Pittsburgh Sleep quality Index, and the 
Short Form 36 Health Survey Questionnaire. Both groups were divided into two subgroups of  younger (<45 years, 14 patients) and older age (>45 years, 16 patients) 
groups, to investigate age-related differences.
Results: ET patients showed significantly worse cognition, depression, anxiety, sleep and NMSS domains (p < 0.001), compared to controls, that negatively 
affected and predicted QoL. Older patients had more cognitive impairment (p = 0.003) and worse sleep/fatigue (p = 0.032) and sexual functions (p = 0.006), com-
pared to younger group.
Discussion: The study supports that NMSs are integral part of  ET, negatively affect QoL, and similarly affect younger and older patients. Therefore, NMSs should 
be explored for proper care of  ET patients.
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Introduction
Essential tremor (ET) is one of  the most common tremor disorders, 
which is characterized mainly by the presence of  action tremor of  the 
hands. Abnormalities in the cerebellothalamocortical loop have been 
implicated in the neuropathogenesis of  ET.1 Apart from motor fea-
tures, significant non-motor symptoms (NMSs) were reported in 
patients with ET by several studies in different populations, including 
cognitive abnormalities, anxiety and depression, pain, hearing impair-
ment, and poor sleep.2–7 However, further studies are warranted to 
explore the biological bases of  these non-motor features and the clini-
cal differences among different populations.8
Recent studies confirmed the impact of  NMSs on patients’ quality of  
life (QoL), which emphasized the importance of  evaluation of  these 
symptoms in the management of  patients with ET. However, the contro-
versy about the nature of  these NMSs as an intrinsic part of  ET, or 
 secondary to tremor severity, has been provoked.9 In addition to NMSs, 
other factors, such as age, neuroticism, and tremor severity, were  correlated 
to impaired QoL of  ET patients.2,8
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Therefore, the current study aimed to investigate the non-motor fea-
tures, including depression, anxiety, sleep quality, and cognitive func-
tions, in Egyptian patients with ET compared to healthy controls and 
their impact on patients’ QoL. Furthermore, the impact of  age was 
studied by comparing early (≤45 years) and older (>45 years) age groups.
Methods
Thirty patients with ET and 30 sex- and age-matched healthy con-
trols were included in this prospective study. Patients were recruited 
from outpatient movement disorders clinic at Ain Shams University 
Hospitals from December 2017 to September 2018. Patients with ET 
were diagnosed according to International Parkinsonism and Movement 
Disorder Society (MDS) diagnostic criteria.10 Exclusion criteria included 
patients with diagnosis of  tremor of  other etiologies (PD, dystonia, 
enhanced physiological tremor, etc.), concurrent or recent exposure to 
tremorogenic drugs, trauma within 3 months before the onset of  tremor, 
and inability of  the patient to perform the tests. The matched controls 
were recruited from healthy persons who accompanied patients to the 
outpatient clinic and were assessed to exclude ET or the presence of  
family history of  tremor. All subjects were non-alcoholics according to 
culture norms and did not take any antidepressants. The study was 
approved by the Ethical Committee of  the Faculty of  Medicine, Ain 
Shams University, which is consistent with the ethical standards of  the 
Declaration of  Helsinki. An informed consent was provided from all 
recruited subjects.
Patients with ET were subjected to comprehensive history, including 
medical comorbidities, and examination, and they were evaluated by 
Fahn Tolosa Marin Tremor Rating Scale (FTMRS) for tremor severity; 
Non-Motor Symptoms Scale (NMSS) for NMSs11; the Montreal 
Cognitive Assessment (MoCA) – Arabic version for cognitive  functions12; 
Beck Depression Inventory (BDI) for depression13; Hamilton Anxiety 
Rating Scale (HARS) for anxiety14; Pittsburgh Sleep Quality Index 
(PSQI) for sleep problems15; and the Arabic version of  Short Form 36 
Health Status Questionnaire (SF-36) for QoL.16
Power analysis calculation for sample size based on previous studies 
was performed using ClinCal software. Calculation yielded a power of  
80% in case of  using 31 per group.
Statistical analysis
The collected data were analyzed using the Statistical Package for 
Social Science (SPSS version 20). Non-numerical data were described 
as frequency and percentage; parametric numerical data were presented 
as mean, standard deviation (± SD) and range; while non-parametric 
data were presented as median and interquartile range (IQR).
The parametric data of  the two study groups were compared by the 
independent student t-test. Correlations of  NMSs were performed by 
the Pearson correlation coefficient. Regression analysis was used to 
detect predictors of  QoL of  the patients group.
Results
The mean age of  ET patients was 45.20 ± 18.10 (range 18–76 years) 
and the mean age of  control subjects was 43.43 ± 17.27 (range 19–77). 
The cases and control subjects were age- and sex-matched. The mean 
age of  onset of  ET was 34.73 ± 16.56 years (range 10–63), the mean 
illness duration was 10.40 ± 7.86 years (3–30), and the mean FTM-TRS 
score was 42.10 ± 13.80 (Table 1). Seventeen patients (42.5%) reported 
positive family history of  ET, and six patients had comorbidities, includ-
ing hypertension, diabetes, and benign prostate hypertrophy (3, 2, and 
1 patient, respectively). No patients reported taking medications that 
might affect NMSs, with only four patients receiving propranolol to 
ameliorate tremor.
Comparison of NMSs and QoL between ET patients and 
the control group
There were significant differences in all tests between ET patients 
and controls (Table 1). Patients with ET showed more cognitive impair-
ment (lower MoCA) (p = 0.021), the significant difference in MoCA 
subtests was mainly in visuospatial/executive functions, recall and 
naming (p < 0.001; 0.006; 0.035, respectively). Also, patients showed 
more depressed mood (higher BDI) (p = 0.001), more anxiety 
(higher HARS) (p ≤ 0.001), and worse sleep quality (higher PSQI) 
(p = 0. 016), compared to controls. Patients’ total NMSS and most of  
its domains showed highly significant worse NMSs compared to con-
trols (p < 0.001). Impaired sleep/fatigue, mood/cognition, and mem-
ory/attention domains were reported by all ET patients (100%), while 
impaired urinary (30%) and gastrointestinal (43.3%) domains were 
less reported. ET patients showed statistically highly significant 
 impairment (lower scores) on all QoL subscales, compared to controls 
(p ≤ 0.001) (Table 1). 
Correlations of neuropsychiatric and NMSS with age, 
 illness duration, and tremor severity
Total NMSS score was positively correlated to age of  onset 
(r = 0.422, p = 0.020) and tremor severity (r = 0.389, p = 0.033). 
Fatigue/sleep domain was positively correlated with age (r = 0.525, 
p = 0.003) and age of  disease onset (r = 0.486, p = 0.006), while car-
diovascular and attention/memory domains were correlated to tremor 
severity (r = 0.567, p = 0.001 and r = 0.519, p = 0.003, respectively) 
(Supplementary Table A).
MoCA total score was negatively correlated with age (r = −0.612, 
p < 0.001) and age of  onset (r = −0.691, p < 0.001), but there was 
no correlation with duration or with tremor severity. Depression was 
positively correlated with tremor severity (r = 0.389, p = 0.033), 
while anxiety and PSQI showed no correlation with age, age 
of  onset, illness duration or with severity of  tremor (Supplementary 
Table A).
Correlations of HRQoL in ET patients
All QoL subscales were negatively and significantly correlated with 
tremor severity (FTMRS) except social functioning (r = −0.348, 
p = 0.059), which means increased severity of  tremor leads to more 
impairment and poor general health status. All QoL subscales were neg-
atively correlated with depression, while anxiety was negatively cor-
related with physical functioning (p = 0.042), mental health (p = 0.002), 
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Table 1.  Comparison of  NMSs and QoL between ET Patients and Controls
ET patients Controls p*
N = 30 N = 30
Age 45.20 ± 18.10 (18–76) 43.43 ± 17.27 (19–77) 0.700
FTMRS_TOTAL 42.10 ± 13.80 (19–79)
(1) Tremor severity 17.10 ± 6.20 (7–33)
(2) Handwriting 15.73 ±5 .30 (8–28)
(3) Functional disability 9.40 ± 3.59 (4–18)
MoCA 25.73 ± 3.04 (21–30) 27.40 ± 2.34 (24–30) 0.021
BDI 13.33±6.00 (70%) 8.77 ± 4.16 (26.7%) 0.001
HARS 15.67 ± 6.25 9.70 ± 4.47 <0.001
PSQI 6.13 ± 2.87 4.40 ± 2.53 0.016
Non-motor symptoms scale*
NMSS Total 58.03 ± 21.50 (100%) 17.20 ± 11.80 (96.7%) <0.001
(1) Cardiovascular 4.17 ± 3.60 (80%) 1.00 ± 1.51 (43.3%) <0.001
(2) Sleep/fatigue 10.53 ± 6.07 (100%) 4.10 ± 3.52 (80%) <0.001
(3) Mood/cognition 17.57 ± 7.67 (100%) 5.43 ± 3.77 (83.3%) <0.001
(4) Perceptual problems 1.37 ± 1.87 (46.6%) 0.23 ± 0.63 (13.3%) 0.003
(5) Attention/memory 8.13 ± 5.19 (100%) 2.83 ± 3.09 (73.3%) <0.001
(6) Gastrointestinal symptoms 1.50 ± 2.70 (43.3%) 0.17 ± 0.46 (13.3%) 0.010
(7) Urinary symptoms 1.10 ± 1.90 (30%) 0.33 ± 0.71 (20%) 0.043
(8) Sexual function 4.13 ± 3.51 (70%) 0.53 ± 1.25 (16.7 %) <0.001
(9) Miscellaneous 9.53 ± 4.88 (96.6%) 2.57 ± 3.01(56.7%) <0.001
HRQoL Subscales**
(1) Physical Functioning (PF) 57.17 ±11.24 79.15±11.43 <0.001
(2) Role physical (RP) 58.12±10.23 77.43±9.72 <0.001
(3) Bodily pain (BP) 58.42±11.43 76.25±7.200 <0.001
(4) General health (GH) 61.72±10.881 77.92±11.077 <0.001
(5) Vitality (VT) 54.23±11.80 74.93±9.44 <0.001
(6) Role-emotional (RE) 52.25±11.62 77.63±8.32 <0.001
(7) Mental health (MH) 51.47±11.13 76.58±11.864 <0.001
(8) Social functioning (SF) 52.71±9.31 75.40±9.062 <0.001
Abbreviations: BDI, Beck Depression Inventory; HARS, Hamilton Anxiety Rating Scale; MoCA, Montreal Cognitive Assessment; NMSS, Non-Motor 
Symptoms Scale; PSQI, Pittsburgh Sleep Quality Index; SD, Standard Deviation. p < 0.05: significant; p < 0.001: highly significant; * Compared by student’s 
t-tests.*Higher scores indicate worse functions.** The physical components of  SF-36 include PF, RP, BP, and GH scales, whereas mental components include VT, 
SF, RE, and MH scales. Higher scores reflect better health status.
role-physical (p = 0.025) and role-emotional (p = 0.010). Role-emotional 
limitations were negatively correlated with sleep quality (r = −0.417, 
p = 0.022) and mental health was positively correlated with MoCA 
scores (r = 0.515, p = 0.004) (Supplementary Table B).
QoL subscales were negatively correlated with total and most of  the 
domains of  NMSS, except perceptual problems, gastrointestinal tract 
and urinary symptoms, which means that an increased severity of  
NMSs is associated with more impairment of  QoL, as shown in Table 2.
Predictors of HRQoL in ET patients
Linear regression analysis showed that the total NMSS was the main 
predictor of  all QoL domains of  ET patients (p < 0.001). MoCA score 
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was a predictor of  perceived intellectual well-being (mental health) 
(β = 0.262, p = 0.040) and general health (β = −0.291, p = 0.030), while 
sleep quality was a predictor of  emotional role (β = −0.224, p = 0.015).
Comparison of NMSs between the younger and the older 
age groups
The patients and control were divided into two subgroups of  younger 
age group (≤45 years of  age, 14 patients and 17 controls) and older age 
group (>45 years of  age, 16 patients and 13 controls), for further analy-
sis of  the impact of  age. The mean age of  the younger ET patients and 
controls were matched, 28.14 ± 8.22 and 29.71 ± 4.77 respectively 
(p = 0.513), and the mean age of  the older ET patients and the controls 
were 60.13 ± 8.09 and 61.39 ± 8.62, respectively (matched, p = 0.689). 
The mean illness duration of  the younger and the older ET patients 
were 8.00 ± 4.72 years and 12.50 ± 9.49 years, respectively, with no 
significant difference (p = 0.119). The mean FTM-TRS scores of  the 
younger and the older ET patients were 38.43 ± 11.43 and 45.31 ± 
15.2, respectively, with no significant difference (p = 0.177). All patients 
with comorbidities were among the older age group.
Compared to their matched controls, the younger ET patients showed 
significant cognitive impairment (p = 0.021) and a significance tendency 
for depression (p = 0.056), while older patients had more depression 
(p = 0.009), with no significant difference of  cognitive impairment. PSQI 
in both groups showed no statistically significant  differences. Regarding 
NMSS, the younger group showed significant differences in total NMSS 
and most of  its domains, compared to younger controls, except urinary 
symptoms (p = 0.136), while the older group showed significant differ-
ences of  total NMSS and most of  its domains, except urinary, gastroin-
testinal, and perceptual symptoms (p = 0.236, 0.249, 0.181, respectively). 
Comparing patients’ age-groups, older patients had more significant 
cognitive impairment (p = 0.003) and worse sleep/fatigue (p = 0.032) 
and sexual (p = 0.006) NMSS domains (Table 3).
ET patients showed statistically highly significant impairment (lower 
scores) on all QoL subscales compared to controls in both age groups 
(all p < 0.001, except general health in older group (p = 0.022)) (Table 3). 
Comparing two patients’ age groups, there was no significant differ-
ences of  QoL subscores except that mental health was worse among the 
older group (p = 0.016). Total NMSS of  both age groups was correlated 
Table 2.  Correlations of  HRQoL with NMSs in ET Patients
PF RP RE VT MH SF BP GH
Cardiovascular r −0.674 −0.623 −0.642 −0.697 −0.610 −0.536 −0.560 −0.627
p <0.001* <0.001* <0.001* <0.001* <0.001* 0.002* 0.001* <0.001*
Sleep/fatigue r −0.601 −0.597 −0.680 −0.553 −0.701 −0.619 −0.515 −0.513
p <0.001* <0.001* <0.001* 0.002* <0.001* <0.001* 0.004* 0.004*
Mood/cognition r −0.640 −0.693 −0.692 −0.547 −0.631 −0.588 −0.561 −0.587
p <0.001* <0.001* <0.001* 0.002* <0.001* 0.001* 0.001* 0.001*
Perceptual abnormalities r −0.064 0.076 0.017 −0.021 0.157 0.205 0.027 −0.113
p 0.738 0.689 0.929 0.911 0.408 0.276 0.889 0.553
Attention/memory r −0.467 −0.408 −0.683 −0.688 −0.677 −0.622 −0.474 −0.585
p 0.009* 0.025* <0.001* <0.001* <0.001* <0.001* 0.008* 0.001*
Gastrointestinal r −0.182 −0.177 −0.354 −0.293 −0.178 −0.311 −0.259 −0.344
p 0.335 0.349 0.055 0.117 0.346 0.094 0.167 0.063
Urinary r −0.185 −0.176 −0.082 −0.163 0.009 −0.015 −0.162 −0.074
p 0.328 0.351 0.668 0.391 0.962 0.935 0.394 0.699
Sexual function r −0.420 −0.334 −0.335 −0.539 −0.249 −0.392 −0.393 −0.275
p 0.021* 0.071 0.070 0.002* 0.185 0.032* 0.032* 0.141
Miscellaneous r −0.533 −0.578 −0.437 −0.569 −0.359 −0.439 −0.607 −0.478
p 0.002* 0.001* 0.016* 0.001* 0.052* 0.015* <0.001* 0.008*
NMS total r −0.858 −0.836 −0.916 −0.904 −0.819 −0.811 −0.800 −0.813
p <0.001* <0.001* <0.001* <0.001* <0.001* <0.001* <0.001* <0.001*
Abbreviations: BP, Bodily Pain; GH, General Health; MH, Mental Health; NMS, Non-Motor Symptoms; PF, Physical Functioning; RE, Role Emotional; 
RP, Role-Physical; SF, Social Functioning; VT, Vitality. p < 0.05: significant. p < 0.001: highly significant. Correlations by Pearson Correlation Coefficient; 
Italics values indicates significant of  p values.
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to all QoL subscores (all p < 0.001, p = 0.010 for social functioning in 
the younger group), except mental health in the younger age group 
(r = −0.451, p = 0.105), with no significant correlation with patients’ 
age, duration of  illness, and tremor severity. 
Discussion
Despite the previous several studies that confirmed the non-motor 
aspects of  ET, further studies are needed to confirm their phenotypes in 
different populations and their correlation to disease severity and dura-
tion. The current study explored several NMSs associated with ET and 
detected their negative impact on QoL. These findings are comparable 
to other studies and confirm the importance of  NMSs as an intrinsic 
component of  ET for proper patient management.
In accordance with prior studies, patients with ET in the current 
study showed significant cognitive impairment, particularly of  visuospa-
tial/executive, naming and recall functions. Previous study reported 
consistent findings with similar impairment of  visuospatial/executive 
and recall functions.17 Similarly, the total MoCA score was impaired in 
Korean ET cohort, but dysfunction was significant in attention.5 Also, 
other studies have reported the presence of  mild cognitive deficits of  
frontal lobe functions similar to Parkinson’s disease (PD), which was 
attributed to dysfunction of  frontocerebellar circuits18,19 and the 
increased risk of  dementia in patients with ET.20
These cognitive functions are similarly affected in the cerebellar 
cognitive affective syndrome (CCAS), which was described in differ-
ent cerebellar disorders by Hoche and colleagues. The CCAS is char-
acterized by impairment of  the executive, linguistic, visuospatial, and 
affective functions.21 Also, cerebellar structural abnormalities were 
confirmed pathologically in ET, which were similar in early onset and 
late onset cases.22 This indicates that cerebellum is implicated in the 
neuropathology of  ET and associated cognitive dysfunction,1 and 
supports the hypothesis that cognitive affection is a part of  the disease 
pathology rather than an age-related symptom. In addition, this 
study found no significant correlation between MoCA scores and dis-
ease duration and tremor severity, similar to Sengul and his col-
leagues,17 but in contrast to another study that detected correlation 
with tremor severity.23
Similar to the previous studies, patients with ET had significantly 
higher frequency and scores of  depression, which was correlated to 
tremor severity.7,24 These results were also consistent with a large door-
to-door study using Hamilton Depression Rating Scale (HDRS).25 
In contrast, previous studies used the Geriatric Depression Scale (GDS) 
that reported significant depression with ET, but without correlation to 
tremor severity,19,26 while a recent study detected non-significant differ-
ence in BDI.9 These variable findings could be explained by using differ-
ent depression scales and variable number of  recruited ET patients, and 







p* Younger  
controls  
≤ 45 years
p* Older controls 
> 45 years
p*
Number 14 16 17 13
Age 28.14 ± 8.22 60.13 ± 8.09 <0.001 29.71 ± 4.77 0.513 61.39 ± 8.62 0.689
MoCA 27.43 ± 2.59 24.25 ± 2.65 0.003 29.12 ± 1.11 0.021 25.15 ±1.41 0.277
BDI 12.43 ± 6.63 14.13 ± 5.49 0.450 8.23 ± 4.92 0.056 9.39 ± 2.96 0.009
PSQI 5.50 ± 2.10 6.69 ± 3.38 0.266 4.24 ± 2.93 0.187 4.62 ± 1.98 0.062
NMSS total 50.43 ± 14.18 64.69 ± 24.86 0.069 10.53 ± 7.38 <0.001 25.92 ± 10.87 <0.001
(1) Cardiovascular 3.79 ± 3.87 4.50 ± 3.43 0.596 0.06 ± 0.24 <0.001 2.23 ± 1.59 0.037
(2) Sleep/fatigue 8.07 ± 5.50 12.69 ± 5.87 0.035 3.53 ± 3.48 0.009 4.85 ± 3.56 <0.001
(3) Mood/cognition 16.43 ± 6.51 18.56 ± 8.64 0.457 4.65 ± 3.2 <0.001 6.46 ± 4.20 <0.001
(4)Perceptual problems 1.71 ± 2.46 1.06 ± 1.123 0.349 0 0.007 0.54 ± 0.88 0.181
(5)Attention/memory 6.29 ± 4.08 9.75 ± 5.63 0.067 1.18 ± 1.29 <0.001 5.00 ± 3.44 0.013
(6) Gastrointestinal symptoms 1.64 ± 2.47 1.38 ± 2.96 0.792 0 0.01 0.39 ± 0.65 0.249
(7) Urinary symptoms 0.64 ± 1.74 1.50 ± 2.00 0.224 0 0.136 0.77 ± 0.93 0.236
(8) Sexual function 2.86 ± 3.39 5.25 ± 3.32 0.006 0 0.002 1.23 ± 1.69 <0.001
(9) Miscellaneous 9.00 ± 5.41 10.00 ± 4.50 0.585 1.12 ± 2.23 <0.001 4.46 ± 2.90 0.001
Abbreviations: BDI, Beck Depression Inventory; MoCA, Montreal Cognitive Assessment; NMSS, Non-Motor Symptoms Scale; PSQI, Pittsburgh Sleep 
Quality Index; SD, Standard Deviation. p < 0.05: significant. p < 0.001: highly significant. *Compared by student’s t-tests; Bold values indicates significant 
of  p values.
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maintain the debate of  the nature of  depression as a reaction to the 
tremor or inherent part of  the illness.
Likewise, ET patients have significantly more anxiety than matched 
controls, which was not correlated with age, age of  illness onset, illness 
duration, or tremor severity. This was similar to the study performed 
by Chandran and his colleagues on patients from an outpatient clinic.7 
Other studies showed significantly higher anxiety in ET patients that 
was correlated with tremor severity.25,27 Our findings support the 
hypothesis that anxiety is a part of  ET and not a secondary phenom-
enon. However, other studies with different results keep the debate still 
open.25,27
The current study detected poor sleep quality of  ET patients 
using PSQI, in agreement with previous studies.7,28 Contrarily, 
another study compared the Epworth Sleepiness Scale (ESS) and the 
PSQI scores in 120 ET patients to controls and reported non-signif-
icant worse sleep quality.29 Quality of  sleep showed no correlation 
with age, age of  illness onset, illness duration, or with tremor sever-
ity, implying that the problem of  sleep regulation is an intrinsic part 
of  ET.
Moreover, patients with ET reported significant impairment of  
all NMSS domains, especially sleep/fatigue, mood/cognition, and 
memory/attention domains, which showed limited correlations 
with patients’ age, and tremor severity, comparable to the findings 
by Lee and his colleagues using similarly the NMSS. Consequently, 
this supports the hypothesis that non-motor manifestations are an 
intrinsic feature of  ET.8,9 Interestingly, similar non-motor profile 
was detected in Egyptian PD patients.30 On the other hand, other 
previous studies used the non-motor symptoms questionnaire 
(NMSQuest) and/or compared patients of  ET to PD patients. An 
epidemiological survey of  Chinese populations reported NMSs 
among ET patients, similar to normal controls, except higher fre-
quency of  restless legs.31 Compared to PD tremor dominant type, 
ET patients showed less NMSs, but with comparable severity,32 
while other studies reported more NMSs among PD patients than 
ET using NMSQuest.33,34 Therefore, further case control studies 
with larger numbers are warranted to confirm the findings of  the 
present study.
The current study confirmed the significant impairment of  self-re-
ported QoL in all sub-domains that were correlated with increased 
tremor severity. These findings are similar to those reported by 
Lorenz and his colleagues.2 However, other studies reported that 
 significant impairment of  QoL was limited to mental domains – 
mental component score (MCS).9,17 The German cohort showed no 
correlation for the impaired MCS; however, physical component 
score was negatively correlated to disease severity.9 This difference 
could be attributed to higher severity of  tremor of  our outpatient 
clinic study compared to the German study that recruited patients 
through media. All QoL domains were negatively correlated to 
depression severity, similar to prior studies.17,35 Likewise, anxiety was 
negatively correlated with physical functioning, mental health, role 
limitations due to physical health, and emotional problems, similar to 
a previous study.17 In addition, the NMSS total score was significantly 
related to and a predictor of  the overall well-being (physical, emo-
tional and intellectual) for patients with ET. Moreover, perceived 
mental health and role-emotional subdomains of  mental component 
of  QoL were correlated to cognition and sleep quality, respectively. 
Few studies correlated QoL of  ET with patients’ cognition and sleep 
quality, with no significant findings.9,17
For further analysis of  the impact of  age, the cases and controls 
were classified into two age subgroups (≤45 and >45 years of  age), 
with matched disease duration and tremor severity. Comparison to 
age-matched controls detected that both age groups showed signifi-
cant NMSs with subsequent impairment on QoL. Both age groups 
with matched disease characteristics showed comparable non-motor 
features, except worse cognition and sexual functions among older 
ET patients. In the older age group, none of  the neuropsychiatric 
or NMSS domains showed correlation with age, illness duration, 
or tremor severity except with that of  sleep quality and fatigue. 
Consequently, non- motor features seem to be disease-associated rather 
than age-associated manifestations. Comorbidities might explain 
worse autonomic functions among the older patients; however, previ-
ous studies reported lack of  this association, implying the need of  fur-
ther studies.7,36
The relatively small number of  patients and the selection bias of  
patients and controls are the main limitations of  the present study. 
Enrollment of  matched controls regarding age, sex, and socioeconomic 
state was adopted to reduce selection bias. Patients enrolled from the 
outpatient clinic might be more disabled and had worse symptoms, in 
contrast to population-based studies, resulting in pursuing medical con-
sultation. However, our findings were comparable with similar case–
control studies of  ET.5,7
Despite these limitations, the current study demonstrated that 
patients with ET presenting to clinics have several NMSs, including 
depression, anxiety, sleep disturbance, and cognitive dysfunction that 
impaired their QoL. Moreover, these non-motor features occur simi-
larly in younger and older patients with minimal differences and are 
mostly integral part of  ET regardless of  tremor severity or patients’ age. 
Consequently, better awareness and assessment of  these symptoms 
result in better management of  patients with ET. Also, further studies 
are required to explore the phenotypes and progression of  these NMSs 
of  ET patients in different populations.
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